Results 261 to 270 of about 57,654 (328)

Immune response to the recombinant herpes zoster vaccine in people living with HIV over 50 years of age compared to non-HIV age-/gender-matched controls (SHINGR'HIV): a multicenter, international, non-randomized clinical trial study protocol. [PDF]

BMC Infect Dis
Hentzien M, Bonnet F, Bernasconi E, Biver E, Braun DL, Munting A, Leuzinger K, Leleux O, Musardo S, Prendki V, Schmid P, Staehelin C, Stoeckle M, Walti CS, Wittkop L, Appay V, Didierlaurent AM, Calmy A.   +17 more
europepmc   +1 more source

Estimated Human and Economic Burden of Four Major Adult Vaccine-Preventable Diseases in the United States, 2013 [PDF]

, 2015
Annette Mercatante, John M. McLaughlin, Joseph Fortuna, Justin J. McGinnis, Litjen Tan   +4 more
core   +1 more source

A health economic model for evaluating a vaccine for the prevention of herpes zoster and post-herpetic neuralgia in the UK. [PDF]

Beillat, Maud, Martin, Monique, McGuire, Alistair, Moore, Lee, Remy, Vanessa   +4 more
core   +1 more source

Effectiveness of the herpes zoster vaccine Zostavax® in Stockholm County, Sweden.

Vaccine, 2019
K. Blom, L. Yin, L. Arnheim‐Dahlström
semanticscholar   +1 more source

Cost-Sharing Requirements for the Herpes Zoster Vaccine in Adults Aged 60. [PDF]

J Pharm Technol, 2019
Tak CR, Kim J, Gunning K, Sherwin CM, Nickman NA, Biskupiak JE.   +5 more
europepmc   +1 more source

Varicella and herpes zoster vaccine development: lessons learned. [PDF]

Expert Rev Vaccines, 2017
Warren-Gash C, Forbes H, Breuer J.
europepmc   +1 more source

Comparing the effectiveness of different vaccines in individuals with and without autoimmune diseases: a study protocol for a target trial emulation. [PDF]

Front Public Health
Denz R, van de Sand H, Basten J, Meiszl K, Tokic M, Oganowski T, Grüter T, Stock S, Simic D, Shukri A, Kiltz U, Zacharopoulou M, Vollmar HC, Otte IC, Giehl C, Lauer R, Suslow A, Stallmach A, Franz A, Marschall U, Saam J, Schumacher C, Blaschke K, Meyer I, Hellwig K, Timmesfeld N, VAC-MAC Consortium.   +26 more
europepmc   +1 more source